Ligand id: 7638

Name: dulaglutide

Compound class Peptide or derivative
Approved drug? Yes (EMA & FDA (2014))
International Nonproprietary Names
INN number INN
9164 dulaglutide
GLP-1Fc | LY2189265 | Trulicity®
Dulaglutide is a GLP-1 mimetic. This treatment has the benefit of being long-acting, with in vivo studies showing peptide immunoreactivity is detactable >6 days following administration [1]. Therefore dulaglutide requires administration only once a week.
Database Links
Specialist databases
IMGT/mAb-DB 394
Other databases
CAS Registry No. 923950-08-7
GtoPdb PubChem SID 223365973
Search PubMed clinical trials dulaglutide
Search PubMed titles dulaglutide
Search PubMed titles/abstracts dulaglutide
Wikipedia Dulaglutide